The calcium-dependent nitric oxide production of human vascular endothelial cells in preeclampsia


      OBJECTIVE: Nitric oxide is an important vasodilator, and in this study we studied whether the calcium-dependent nitric oxide production capacity of human umbilical vein endothelial cells was affected by preeclampsia. STUDY DESIGN: Human umbilical vein endothelial cells were isolated from 11 preeclamptic and 10 normotensive pregnancies. The maximal calcium ionophore A23187-stimulated nitric oxide production capacity was measured as accumulation of nitrate and nitrite into the culture medium, and it was related to the number of viable endothelial cells by measurement of their mitochondrial dehydrogenase activity. RESULTS: The cell number - related nitric oxide production capacity was similar in preeclamptic and normotensive pregnancies. The total nitric oxide production of cells from preeclamptic pregnancies was significantly lower (p < 0.001). This difference, however, was mainly caused by larger amount of viable endothelial cells recovered from normotensive pregnancies. CONCLUSION: The maximal calcium-dependent nitric oxide production capacity of individual human umbilical vein endothelial cells is not affected by preeclampsia. (AM J OBSTET GYNECOL 1996;174:1056-60.)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Roberts JM
        • Redman CWG.
        Pre-eclampsia: more than pregnancy-induced hypertension.
        Lancet. 1993; 341: 1447-1450
        • Ylikorkala O
        • Viinikka L.
        The role of prostaglandins in obstetrical disorders.
        Baillieres Clin Obstet Gynaecol. 1992; 6: 809-827
        • Moncada S
        • Palmer RMJ
        • Higgs EA.
        Nitric oxide: physiology, pathophysiology and pharmacology.
        Pharmacol Rev. 1991; 43: 109-142
        • Myatt L
        • Brewer A
        • Brockman DE.
        The action of nitric oxide in the perfused human fetal-placental circulation.
        AM J OBSTET GYNECOL. 1991; 164: 687-692
        • Yallampalli C
        • Garfield RE.
        Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia.
        AM J OBSTET GYNECOL. 1993; 169: 1316-1320
        • Sarrel PM
        • Lindsay DC
        • Poole-Wilson PA
        • Collins P.
        Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia.
        Lancet. 1990; 336: 1030-1032
        • Pinto A
        • Sorrentino R
        • Sorrentino P
        • et al.
        Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension.
        AM J OBSTET GYNECOL. 1991; 164: 507-513
        • MacCarthy AL
        • Woolfson RG
        • Raju SK
        • Poston L.
        Abnormal endothelial cell function of resistance arteries from women with preeclampsia.
        AM J OBSTET GYNECOL. 1993; 168: 1323-1330
        • Orpana A
        • Viinikka L
        • Ylikorkala O.
        An in vitro model for studies on nitric oxide production in HUVECs.
        ([Abstract 219])in: Proceedings of the eighth international symposium on the biology of vascular cells, Heidelberg, Germany, : International Symposium on the Biology of Vascular Cells, HeidelbergSeptember 30 - October 4, 1994
        • Jaffe ER
        • Nachman RL
        • Becker CG
        • Minick CR.
        Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria.
        J Clin Invest. 1973; 52: 2745-2756
        • Scudiero DA
        • Shoemaker RH
        • Paull KD
        • et al.
        Evaluation of a soluble tetrazolium/fomazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.
        Cancer Res. 1988; 48: 4827-4833
        • Shanklin DR
        • Sibai B.
        Ultrastructural aspects of preeclampsia, II: mitochondrial changes.
        AM J OBSTET GYNECOL. 1990; 163: 943-953
        • Torbergsen T
        • Øian P
        • Mathiesen E
        • Borud O
        Pre-eclampsia - a mitochondrial disease.
        Acta Obstet Gynecol Scand. 1989; 68: 145-148
        • Cameron IT
        • van Papendorf CL
        • Palmer RMJ
        • Smith SK
        • Moncada S.
        Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy.
        Hypertens Pregnancy. 1993; 12: 85-92
        • Seligman SP
        • Buyon JP
        • Clancy RM
        • Young BK
        • Abramson SB.
        The role of nitric oxide in pathogenesis of preeclampsia.
        AM J OBSTET GYNECOL. 1994; 171: 944-948
        • Benjamin N
        • Vallace P.
        Plasma nitrite as a marker of nitric oxide production.
        Lancet. 1994; 344: 960
        • Wang Y
        • Scott W
        • Parnell R
        • Han J.
        Placental production of nitric oxide and endothelin in normal and preeclamptic pregnancies.
        Hypertens Pregnancy. 1994; 13: 171-178
        • Fickling SA
        • Williams D
        • Vallance P
        • Nussey SS
        • Whitley GSJ.
        Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia.
        Lancet. 1993; 342: 242-243
        • Avela K
        • Mikkola T
        • Orpana A
        • Viinikka L
        • Ylikorkala O.
        Effect of labetalol on the release of prostacyclin and endothelin-1 by cultured human umbilical vein endothelial cells and on the excretion of prostacyclin and thromboxane metabolites in preeclamptic patients.
        Hypertens Pregnancy. 1995; 14: 361-369